Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019: A review and meta-analytic approach

Clinical Trials(2021)10.1177/1740774520984870Source: DataRank Database

Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019: A review and meta-analytic approach is a research paper published in Clinical Trials (2021). On theSindex it has a DataRank of 0. It has been cited 49 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access49 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 6.17)OA: greenTopics (50)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Brian Williams ORCID,Xiaolu Situ,Victoria Landsman ORCID,Jeehyoung Kim ORCID,Alex Moroz ORCID

Live enrichment

PubMed:33478258 PMC:PMC8172416 OpenAlex:https://openalex.org/W3125944419

national institutes of health

Grant: R01 AR076088, UL1 TR001860

NIAMS NIH HHS

Grant: R01 AR076088

NCATS NIH HHS

Grant: UL1 TR001860

National Institutes of Health

Grant: 5UL1TR001860-10

UC Davis Clinical and Translational Science Center

National Institutes of Health

Grant: 5R01AR076088-03

Total-Body PET/CT for assessing Rheumatoid Arthritis Disease Activity and Treatment Response

FWCI

6.17

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8172416

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/1740774520984870

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/1740774520984870

journalhttps://doi.org/10.1177/1740774520984870

Fields of Study

Musculoskeletal pain and rehabilitationMeta-analysis and systematic reviewsPain Management and Placebo Effect03 medical and health sciences0302 clinical medicine

MeSH Terms

Back PainHumansBiasRandomized Controlled Trials as Topic

Keywords

BlindingMedicineRandomized controlled trialMeta-analysisPhysical therapyN of 1 trialAlternative medicinePlaceboInternal medicineSystematic reviewBack PainClinical TrialGuess4905 Statistics (for-2020)Statistics & ProbabilityClinical SciencesClinical Trials and Supportive ActivitiesClinical Trials and Supportive Activities (rcdc)610Clinical and health psychologyClinical Research (rcdc)BiasClinical Research1103 Clinical Sciences (for)Humans32 Biomedical and Clinical Sciences (for-2020)3202 Clinical Sciences (for-2020)Randomized Controlled Trials as TopicHumans (mesh)Biomedical and Clinical SciencesChronic Pain (rcdc)Statistics & Probability (science-metrix)Pain ResearchStatisticsPain Research (rcdc)Back Pain (mesh)Bias (mesh)Randomized Controlled Trials as Topic (mesh)0104 Statistics (for)5203 Clinical and health psychology (for-2020)Chronic Pain

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being

sj-pdf-3-ctj-10.1177_1740774520984870 – Supplemental material for Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019

10.25384/sage.13646391SAGE Journals

sj-pdf-2-ctj-10.1177_1740774520984870 – Supplemental material for Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019

10.25384/sage.13646388SAGE Journals

sj-pdf-1-ctj-10.1177_1740774520984870 – Supplemental material for Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019

10.25384/sage.13646385SAGE Journals

Additional file 1 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.25107753.v1figshare

Additional file 1 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.25107753figshare

Additional file 2 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.25107934.v1figshare

Additional file 2 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.25107934figshare

Additional file 1 of Feasibility of blinding spinal manual therapy interventions among participants and outcome assessors: protocol for a blinding feasibility trial

10.6084/m9.figshare.25744350.v1figshare

Additional file 1 of Feasibility of blinding spinal manual therapy interventions among participants and outcome assessors: protocol for a blinding feasibility trial

10.6084/m9.figshare.25744350figshare

Additional file 2 of Feasibility of blinding spinal manual therapy interventions among participants and outcome assessors: protocol for a blinding feasibility trial

10.6084/m9.figshare.25744428.v1figshare

Additional file 2 of Feasibility of blinding spinal manual therapy interventions among participants and outcome assessors: protocol for a blinding feasibility trial

10.6084/m9.figshare.25744428figshare

Additional file 3 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674224.v1figshare

Additional file 3 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674224figshare

Additional file 4 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674227.v1figshare

Additional file 4 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674227figshare

Additional file 5 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674230.v1figshare

Additional file 5 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674230figshare

Additional file 6 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674233.v1figshare

Additional file 6 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674233figshare

Additional file 7 of Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students

10.6084/m9.figshare.26674236.v1figshare